Skip to main content
ConductScienceScienceDex

Pascal Geldsetzer

NIH Rank #7948
Unclaimed recordClaim profile
  • R01 Holder
  • Early Career

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID 16116524Search this ID in NIH RePORTER
ScienceDex PI coverage
FY2024 through FY2026Career claims are limited to the years shown.

FY2026 award categories

  • Internal Medicine

NIH Funding · FY2025

Linked Award Amount
$1.8M
Full award amounts, FY2025
Award Records
4
Records listing this PI
Award-Linked Rank
#7,948
By linked amount among FY2025 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for Pascal Geldsetzer. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2025 NIH portfolio memberships

No institute-level portfolio release is available for this scientist and fiscal year yet. Existing award history remains unchanged above.

Researcher-associated datasets

These datasets are linked to this researcher's ShareScore identity. This does not by itself prove that an NIH portfolio funded each dataset.

No compatible author-to-dataset release is published. Dataset records are unavailable, not zero.

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

FY2025 award records by amount

NIH award records listing Pascal Geldsetzer as a PI. Multi-PI records show the full award amount for context.

  • 5R01AG084535-02R01
    The effect of antihypertensive and statin therapy on dementia incidence: a novel analytical approach in large electronic health record datasets with long follow-up times and minimal loss to follow-up
    Stanford University
    $736K
    award amount
  • 5R01HL166509-03R01
    The relationship between sodium intake and mortality: a case-cohort study in a population-based cohort of 148,000 adults with both 24-hour and spot urine samples
    Stanford University
    $505K
    award amount
  • 5DP2AI171011-04DP2
    The impact of clinical interventions for sepsis in routine care and among detailed patient subgroups: A novel approach for causal effect estimation in electronic health record data
    Stanford University
    $472.2K
    award amount
  • 3R01HL166509-03S1R01
    The relationship between sodium intake and mortality: a case-cohort study in a population-based cohort of 148,000 adults with both 24-hour and spot urine samples
    Stanford University
    $68.8K
    award amount

Award organization

Organizations that administered FY2025 awards listing Pascal Geldsetzer as a PI.

FY2025 award administered by Stanford University (CA).

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2024
    First NIH Award
    Stanford University
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    $2M Cumulative Funding
  5. 2024
    Entered Top 50% Nationally
    Ranked #3948
  6. 2024
    Entered Top 25% Nationally
    Ranked #3948
  7. 2025
    R01 Grant Holder
  8. 2026
    $5M Cumulative Funding

Shared-award investigators

Other investigators listed on at least one of the same NIH award records as Pascal Geldsetzer.

Marshall Burke
Stanford University
1
shared award

Explore further

Find collaborators for Pascal Geldsetzer

Search NIH-funded principal investigators by topic, department, or activity.

Open Find Collaborators →

Benchmark grant budgets

Compare median NIH grant budgets across departments, mechanisms, and years.

Open Grant Budget Benchmark →